Global Autoimmune Drugs Market 2024-2028

Description

List of Tables

The autoimmune drugs market is forecasted to grow by USD 33218.8 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the autoimmune drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong R&D pipeline, targeted therapeutic mechanism of biologics, and introduction of affordable biosimilars.

Technavio's autoimmune drugs market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.23%
CAGR	6.78%
Incremental Value	$33218.8 mn

By Therapy Area

Rheumatoid arthritis
Multiple sclerosis
Psoriasis
Inflammatory bowel disease
Others

By Distribution Channel

Hospital
Pharmacy
Drug store/Retail pharmacy
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the reduction in cost of autoimmune drugs as one of the prime reasons driving the autoimmune drugs market growth during the next few years. Also, market dominance by TNF-alpha inhibitors and development and approval of new drugs will lead to sizable demand in the market.

The report on the autoimmune drugs market covers the following areas:

Autoimmune drugs market sizing
Autoimmune drugs market forecast
Autoimmune drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading autoimmune drugs market vendors that include AbbVie Inc., AdvaCare Pharma, Amgen Inc., AstraZeneca PLC, Bristol Myers Squibb Co., Cardinal Health Inc., Delphis Pharmaceutical India, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Johnson and Johnson Services Inc., Medexus Pharmaceuticals Inc., Parvus Therapeutics Inc., Prometheus Laboratories, Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Wellona Pharma. Also, the autoimmune drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR70662

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Therapy Area
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Autoimmune Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Autoimmune Drugs Market 2018 - 2022 ($ million)
4.2 Therapy Area segment analysis 2018 - 2022
- Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy Area

6.1 Market segments
- Chart on Therapy Area - Market share 2023-2028 (%)
- Data Table on Therapy Area - Market share 2023-2028 (%)
6.2 Comparison by Therapy Area
- Chart on Comparison by Therapy Area
- Data Table on Comparison by Therapy Area
6.3 Rheumatoid arthritis - Market size and forecast 2023-2028
- Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
- Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
- Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
- Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
6.4 Multiple sclerosis - Market size and forecast 2023-2028
- Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
- Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
- Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
- Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
6.5 Psoriasis - Market size and forecast 2023-2028
- Chart on Psoriasis - Market size and forecast 2023-2028 ($ million)
- Data Table on Psoriasis - Market size and forecast 2023-2028 ($ million)
- Chart on Psoriasis - Year-over-year growth 2023-2028 (%)
- Data Table on Psoriasis - Year-over-year growth 2023-2028 (%)
6.6 Inflammatory bowel disease - Market size and forecast 2023-2028
- Chart on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
- Data Table on Inflammatory bowel disease - Market size and forecast 2023-2028 ($ million)
- Chart on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
- Data Table on Inflammatory bowel disease - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Therapy Area
- Market opportunity by Therapy Area ($ million)
- Data Table on Market opportunity by Therapy Area ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Chart on Distribution Channel - Market share 2023-2028 (%)
- Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
7.3 Hospital - Market size and forecast 2023-2028
- Chart on Hospital - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospital - Market size and forecast 2023-2028 ($ million)
- Chart on Hospital - Year-over-year growth 2023-2028 (%)
- Data Table on Hospital - Year-over-year growth 2023-2028 (%)
7.4 Pharmacy - Market size and forecast 2023-2028
- Chart on Pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Pharmacy - Year-over-year growth 2023-2028 (%)
7.5 Drug store/retail pharmacy - Market size and forecast 2023-2028
- Chart on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Data Table on Drug store/retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Chart on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
- Data Table on Drug store/retail pharmacy - Year-over-year growth 2023-2028 (%)
7.6 Online - Market size and forecast 2023-2028
- Chart on Online - Market size and forecast 2023-2028 ($ million)
- Data Table on Online - Market size and forecast 2023-2028 ($ million)
- Chart on Online - Year-over-year growth 2023-2028 (%)
- Data Table on Online - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
12.4 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
12.6 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
12.7 Cardinal Health Inc.
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
12.8 Delphis Pharmaceutical India
- Delphis Pharmaceutical India - Overview
- Delphis Pharmaceutical India - Product / Service
- Delphis Pharmaceutical India - Key offerings
12.9 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key news
- Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
12.11 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
- Hikma Pharmaceuticals Plc - Overview
- Hikma Pharmaceuticals Plc - Business segments
- Hikma Pharmaceuticals Plc - Key news
- Hikma Pharmaceuticals Plc - Key offerings
- Hikma Pharmaceuticals Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
12.14 Parvus Therapeutics Inc.
- Parvus Therapeutics Inc. - Overview
- Parvus Therapeutics Inc. - Product / Service
- Parvus Therapeutics Inc. - Key offerings
12.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
12.16 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
12.17 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
- 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations